Related content

Risk of Diabetic Ketoacidosis after Exposure to Risperidone or Olanzapine

By Ramaswamy Krishnan  

Drug Safety, Vol. 30, Iss. 7, 2007-01 ,pp. : 589-599

Adis International

Access to resources Recommend Favorite

Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine

By Sebens J.B.   Koch T.   Ter Horst G.J.   Korf J.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers

By Giménez Sandra   Clos Susana   Romero Sergio   Grasa Eva   Morte Adelaida   Barbanoj Manuel  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 507-516

Springer Publishing Company

Access to resources Recommend Favorite

CHARACTERIZATION OF INHIBITION BY CHRONIC TREATMENT WITH LITHIUM ION ON NERVE GROWTH FACTOR-INDUCED NEURONAL DIFFERENTIATION OF RAT PC12 PHEOCHROMOCYTOMA CELLS

By Harada Hitoshi   Sugiyama Tomohiko   Suketa Yasunobu  

Journal of Toxicology and Environmental Health, Vol. 49, Iss. 2, 1996-09 ,pp. : 197-206

Taylor & Francis Ltd

Access to resources Recommend Favorite

Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol: Results of the EIRE Study

By Bobes J.  

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 609-622

Adis International

Access to resources Recommend Favorite